Aprotinin and thromboembolism in liver transplantation: is there really a causal effect?

[1]  C. Legnani,et al.  Aprotinin in orthotopic liver transplantation: Evidence for a prohemostatic, but not a prothrombotic, effect , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[2]  S. Aggarwal,et al.  Intracardiac thrombus formation and pulmonary thromboembolism immediately after graft reperfusion in 7 patients undergoing liver transplantation , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  D. Raines,et al.  Aprotinin administration and pulmonary thromboembolism during orthotopic liver transplantation: report of two cases. , 2001, Anesthesia and analgesia.

[4]  M. Laffan,et al.  The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1. , 2000, The Journal of thoracic and cardiovascular surgery.

[5]  M. Prins,et al.  Pharmacological Strategies to Decrease Excessive Blood Loss in Cardiac Surgery: Meta‐analysis of Clinically Relevant Endpoints* , 2001 .

[6]  E. Jaurrieta,et al.  The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: A randomized clinical study , 1997, Hepatology.

[7]  L. Muhlbaier,et al.  Aprotinin: safe and effective only with the full-dose regimen. , 1996, The Annals of thoracic surgery.

[8]  L. Goodnough,et al.  Aprotinin Prolongs Whole Blood Activated Partial Thromboplastin Time but Not Whole Blood Prothrombin Time in Patients Undergoing Cardiac Surgery , 1995, Anesthesia and analgesia.

[9]  R. E. Clark,et al.  A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. , 1995, Circulation.

[10]  F. J. Farrell,et al.  Outcome of liver transplantation in patients with hemochromatosis , 1994, Hepatology.

[11]  P. Duvaldestin,et al.  A fatal thrombotic complication during liver transplantation after aprotinin administration. , 1994, Transplantation.

[12]  J. Chabbat,et al.  Aprotinin is a competitive inhibitor of the factor VIIa-tissue factor complex. , 1993, Thrombosis research.

[13]  J. Crow,et al.  Pulmonary platelet aggregates: possible cause of sudden peroperative death in adults undergoing liver transplantation. , 1993, Journal of clinical pathology.

[14]  S. Feinstein,et al.  Right Heart Dysfunction, Pulmonary Embolism, and Paradoxical Embolization during Liver Transplantation: A Transesophageal Two‐Dimensional Echocardiographic Study , 1989, Anesthesia and analgesia.

[15]  J. Sarner,et al.  Massive pulmonary thromboembolism during liver transplantation. , 1988, Anesthesia and analgesia.